Cowen raised its price target on Array BioPharma (NASDAQ: ARRY) to $19.00 (from $17.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS View Analyst PT Change

Array BioPharma (ARRY) PT Raised to $24 at Cantor FitzgeraldFebruary 8, 2018 6:34 AM Array BioPharma (ARRY) PT Raised to $20 at Leerink PartnersFebruary 7, 2018 7:40 AM Array BioPharma (ARRY) PT Raised to $23 at StifelFebruary 7, 2018 6:27 AM Array Biopharma (ARRY) Tops Q2 EPS by 6cFebruary 6, 2018 8:08 AM Array BioPharma Reports Financial Results For The Second Quarter of Fiscal 2018February 6, 2018 8:05 AM